KLIPPEL-TRENAUNAY SYNDROME
Clinical trials for KLIPPEL-TRENAUNAY SYNDROME explained in plain language.
Never miss a new study
Get alerted when new KLIPPEL-TRENAUNAY SYNDROME trials appear
Sign up with your email to follow new studies for KLIPPEL-TRENAUNAY SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets root cause of rare overgrowth diseases in kids and adults
Disease control Recruiting nowThis study tests a new drug, RLY-2608, designed to block a faulty protein that causes abnormal growth in people with PIK3CA-related overgrowth spectrum (PROS) and related malformations. The trial enrolls 277 adults and children to see if the drug can safely shrink overgrown tissu…
Matched conditions: KLIPPEL-TRENAUNAY SYNDROME
Phase: PHASE2 • Sponsor: Relay Therapeutics, Inc. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Rare disease mystery: researchers launch global registry to track lymphatic disorders
Knowledge-focused Recruiting nowThis study is creating a registry of up to 1,000 people with rare lymphatic anomalies (such as lymphatic malformation, Gorham-Stout disease, and CLOVES syndrome). Researchers will collect information from medical records and annual questionnaires to learn how these conditions pro…
Matched conditions: KLIPPEL-TRENAUNAY SYNDROME
Sponsor: Boston Children's Hospital • Aim: Knowledge-focused
Last updated May 11, 2026 20:40 UTC